Transdermal iontophoresis. Pharmacokinetic considerations.
Singh
P
P
Department of Dermatology, University of California-San Francisco.
Maibach
H I
HI
D000279:Administration, Cutaneous; D006801:Humans; D007478:Iontophoresis / Q000009:adverse effects; D010455:Peptides / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010599:Pharmacokinetics; D011506:Proteins / Q000008:administration & dosage* / Q000493:pharmacokinetics
D010455:Peptides; D011506:Proteins